To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NDC80TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
216 supporting clones for gene NDC80 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI093871 cervix .a -11 to 765 1 to 775       775/839
(92 %)
16 diff
(98.1 %id)
DB114163 thymus .a -11 to 516 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB114313 thymus .a -11 to 536 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
AA249583   .a -10 to 240 1 to 247       247/250
(98 %)
9 diff
(96.4 %id)
AA249666   .a -10 to 194 1 to 204       204/204
(100 %)
9 diff
(95.6 %id)
N88235   .a -10 to 273 1 to 271       274/321
(85 %)
28 diff
(91.3 %id)
DN998342 bone marrow .a -10 to 640 1 to 651       651/651
(100 %)
4 diff
(99.4 %id)
BQ425406 melanotic melanoma, skin .a 1 to 858 9 to 869   tiling clone,   869/882
(98 %)
3 diff
(99.7 %id)
BM476696 leiomyosarcoma, uterus .a 1 to 858 8 to 872       851/1115
(76 %)
36 diff
(96.8 %id)
AA312280   .a 1 to 430 7 to 437       437/437
(100 %)
2 diff
(99.6 %id)
CN294245 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1 to 761 7 to 770       770/770
(100 %)
6 diff
(99.3 %id)
BP430527   .a 1 to 341 7 to 347       347/347
(100 %)
4 diff
(98.9 %id)
AW955129   .a 1 to 647 6 to 652       652/655
(99 %)
10 diff
(98.5 %id)
DA419915 cord Blood .a 1 to 565 7 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BX353230 Neuroblastoma Cot 25-normalized .a 1 to 954 6 to 955       955/958
(99 %)
24 diff
(97.5 %id)
AL527360 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1 to 960 6 to 959       959/965
(99 %)
15 diff
(98.5 %id)
BJ991538 hepatoblastoma .a 1 to 580 6 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BF665251 brain, primitive neuroectoderm .a 1 to 678 6 to 688       688/836
(82 %)
23 diff
(97.3 %id)
CN294239 embryonic stem cells, DMSO-treated H9 cellline .a 1 to 537 5 to 541       541/541
(100 %)
1 diff
(99.9 %id)
CN294244 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1 to 516 5 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BF666100 brain, primitive neuroectoderm .a 1 to 519 5 to 548       545/548
(99 %)
37 diff
(93.3 %id)
DA050103   .a 1 to 547 5 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
BF976962 melanotic melanoma, high MDR, skin .a 1 to 678 4 to 689       689/710
(97 %)
24 diff
(96.7 %id)
DA479788   .a 1 to 537 4 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA551982   .a 1 to 509 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
BF700934 brain, primitive neuroectoderm .a 4 to 631 1 to 624       624/871
(71 %)
22 diff
(97.5 %id)
BG612856 embryonal carcinoma, testis .a 4 to 502 1 to 500       500/503
(99 %)
6 diff
(98.9 %id)
BE561023 Burkitt lymphoma, lymph .a 6 to 773 1 to 775   available from MGC,   775/859
(90 %)
18 diff
(98.0 %id)
AF017790   .a 10 to 2078 18 to 2086 exact AAA   2069/2086
(99 %)
6 diff
(99.8 %id)
CN294238 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 13 to 403 1 to 391       391/391
(100 %)
3 diff
(99.3 %id)
BF684028 leiomyosarcoma cell line, uterus .a 17 to 763 1 to 741       741/919
(80 %)
15 diff
(98.4 %id)
BU507911 leiomyosarcoma, uterus .a 25 to 961 1 to 935       935/935
(100 %)
7 diff
(99.3 %id)
CR609890 fetal liver .a 27 to 2044 1 to 2018 exact     2018/2018
(100 %)
0 diff
(100 %id)
AL531915 brain, fetal liver, Liver, neuroblastoma cells .a 27 to 1053 1 to 1020       1020/1058
(96 %)
10 diff
(99.1 %id)
CN294233 embryonic stem cells, cell lines H1, H7, andH9 .a 32 to 614 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DR763377 embryonic stem .a 45 to 873 1 to 829       829/829
(100 %)
0 diff
(100 %id)
R92253 liver and spleen .a 46 to 401 1 to 358       358/441
(81 %)
6 diff
(98.7 %id)
DA051790   .a 50 to 640 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DW442688 Liver .a 54 to 269 17 to 232       216/233
(92 %)
9 diff
(96.2 %id)
BP369219 testis .a 85 to 663 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
DA003052   .a 88 to 433 128 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
AK289396   .a 88 to 2085 128 to 2125 exact     2125/2125
(100 %)
0 diff
(100 %id)
AK313184   .a 88 to 2025 126 to 2063 exact     2063/2063
(100 %)
2 diff
(100.0 %id)
DA019356   .a 88 to 492 147 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA022482   .a 88 to 542 128 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA034022   .a 88 to 534 129 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BC035617 Brain, adult medulla .a 88 to 2085 105 to 2102 exact tiling clone, available from MGC, AAA   2102/2102
(100 %)
0 diff
(100 %id)
BE940500 uterus_tumor .a 88 to 420 129 to 461       434/461
(94 %)
8 diff
(98.3 %id)
DA043783 bladder .a 88 to 531 128 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CN294234 embryonic stem cells, DMSO-treated H9 cellline .a 88 to 639 110 to 661       661/661
(100 %)
1 diff
(99.9 %id)
CN294235 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 88 to 613 112 to 637       637/637
(100 %)
2 diff
(99.7 %id)
CN294240 embryonic stem cells, DMSO-treated H9 cellline .a 88 to 537 107 to 556       554/556
(99 %)
7 diff
(98.8 %id)
CN294241 embryonic stem cells, cell lines H1, H7, andH9 .a 88 to 607 163 to 684       667/684
(97 %)
8 diff
(98.9 %id)
CN294243 embryonic stem cells, DMSO-treated H9 cellline .a 88 to 590 116 to 618       618/618
(100 %)
1 diff
(99.9 %id)
DA445269 tongue, tumor tissue .a 88 to 500 128 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA473757   .a 88 to 535 128 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA480755   .a 88 to 516 128 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AL711170 human skeletal muscle .a 88 to 506 151 to 569       569/569
(100 %)
1 diff
(99.9 %id)
AL710845 human skeletal muscle .a 88 to 636 101 to 649       649/649
(100 %)
1 diff
(99.9 %id)
DN912297   .a 88 to 634 104 to 651       651/651
(100 %)
1 diff
(99.9 %id)
DB451073 testis .a 88 to 440 122 to 474       474/474
(100 %)
1 diff
(99.8 %id)
BP239153 Liver .a 88 to 603 105 to 620       620/620
(100 %)
5 diff
(99.2 %id)
AU099103   .a 88 to 227 161 to 300       300/300
(100 %)
7 diff
(97.7 %id)
BP242960 Liver .a 88 to 499 161 to 572       572/572
(100 %)
7 diff
(98.8 %id)
BC010171 Lymph, Burkitt lymphoma .a 88 to 963 102 to 976   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 976/978
(99 %)
6 diff
(99.4 %id)
BE566742 bladder, carcinoma, cell line .a 88 to 497 122 to 537       537/537
(100 %)
21 diff
(96.1 %id)
BE565202 bladder, carcinoma, cell line .a 88 to 719 106 to 751       651/792
(82 %)
25 diff
(96.9 %id)
BE564344 bladder, carcinoma, cell line .a 88 to 548 124 to 581       581/891
(65 %)
9 diff
(99.0 %id)
BE903220 choriocarcinoma, placenta .a 88 to 688 165 to 765       743/766
(96 %)
10 diff
(98.7 %id)
BC005239 Bladder, carcinoma .a 88 to 1657 144 to 1713   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1713/1726
(99 %)
7 diff
(99.6 %id)
BF029347 bladder, carcinoma, cell line .a 88 to 660 124 to 694   available from MGC,   694/817
(84 %)
38 diff
(95.4 %id)
BF246890 brain, glioblastoma .a 88 to 440 128 to 481       481/481
(100 %)
9 diff
(98.2 %id)
BF244797 brain, glioblastoma .a 88 to 674 104 to 683       683/865
(78 %)
23 diff
(97.4 %id)
BF219086 brain, glioblastoma .a 88 to 642 104 to 664       660/782
(84 %)
20 diff
(97.5 %id)
BF667950 brain, primitive neuroectoderm .a 88 to 666 104 to 683       683/827
(82 %)
16 diff
(98.1 %id)
BF977553 melanotic melanoma, high MDR, skin .a 88 to 584 123 to 630       630/816
(77 %)
26 diff
(96.9 %id)
BG500282 adenocarcinoma, Prostate .a 88 to 592 138 to 643       643/643
(100 %)
5 diff
(99.3 %id)
BG531886 embryonal carcinoma, testis .a 88 to 576 151 to 633       631/906
(69 %)
15 diff
(98.4 %id)
BG532554 embryonal carcinoma, testis .a 88 to 657 175 to 756       756/756
(100 %)
26 diff
(96.6 %id)
BI825656 brain, medulla .a 88 to 765 104 to 790       790/1012
(78 %)
18 diff
(98.3 %id)
BQ233581 leiomyosarcoma, uterus .a 88 to 573 144 to 635       635/1280
(49 %)
9 diff
(99.3 %id)
CD557751 testis .a 88 to 765 145 to 826       805/901
(89 %)
13 diff
(98.6 %id)
DA609875   .a 88 to 525 127 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA612599   .a 88 to 539 134 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA618101   .a 88 to 536 126 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
TI_57170718   .a 88 to 678 171 to 762       710/1079
(65 %)
9 diff
(99.2 %id)
BP282259 bone marrow .a 88 to 541 130 to 584       582/586
(99 %)
8 diff
(98.7 %id)
BP283529 bone marrow .a 88 to 549 137 to 598       598/598
(100 %)
2 diff
(99.7 %id)
DA660346   .a 88 to 530 128 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
NM_006101.2   .a 88 to 2085 174 to 2171 exact RefSeq, AAA   2171/2171
(100 %)
0 diff
(100 %id)
DA730035   .a 88 to 765 128 to 804   capped   803/809
(99 %)
2 diff
(99.8 %id)
AU129601   .a 88 to 738 122 to 786   capped   785/792
(99 %)
15 diff
(98.2 %id)
DA815503   .a 88 to 528 128 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA818180   .a 88 to 511 138 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA821790 pericardium .a 88 to 539 104 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA835740 placenta .a 88 to 511 104 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
BM828736 Ascites, stomach .a 88 to 539 122 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DA903159   .a 88 to 522 134 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA910990   .a 88 to 515 122 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA911000   .a 88 to 524 122 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA912679   .a 88 to 493 162 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA972092 synovial membrane tissue from rheumatioidarthritis .a 88 to 539 122 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA983880 synovial membrane tissue from rheumatioidarthritis .a 88 to 521 129 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BM194061 leukopheresis .a 88 to 405 148 to 465       465/466
(99 %)
4 diff
(99.2 %id)
DB023753 testis .a 88 to 475 147 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB035228 testis .a 88 to 532 122 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB035553 testis .a 88 to 512 128 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB049418 testis .a 88 to 496 156 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB104879 thymus .a 88 to 526 133 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB109087 thymus .a 88 to 522 129 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB110276 thymus .a 88 to 521 147 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB116308 thymus .a 88 to 500 130 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB121707 thymus .a 88 to 520 135 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB129955 thymus .a 88 to 505 147 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB130482 thymus .a 88 to 493 133 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DB246622   .a 88 to 761 128 to 797   capped   797/844
(94 %)
17 diff
(98.0 %id)
TI_1948139567   .a 95 to 767 128 to 801       674/1365
(49 %)
13 diff
(99.1 %id)
TI_1948139568   .a 95 to 1108 124 to 1135       1012/1195
(84 %)
32 diff
(97.4 %id)
TI_1948139570   .a 95 to 679 128 to 715       588/1322
(44 %)
23 diff
(98.3 %id)
TI_1948139811   .a 95 to 764 125 to 795       671/1341
(50 %)
19 diff
(98.6 %id)
TI_1948139812   .a 95 to 1039 126 to 1081       954/1224
(77 %)
38 diff
(96.9 %id)
TI_1948140072   .a 95 to 675 126 to 710       585/1360
(43 %)
32 diff
(97.7 %id)
TI_1948140075   .a 95 to 678 127 to 715       589/1297
(45 %)
34 diff
(97.4 %id)
TI_1948140321   .a 95 to 804 126 to 839       714/1306
(54 %)
14 diff
(99.0 %id)
CV030676 mixed .a 97 to 716 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
EH322556   .a 164 to 257 1 to 94       94/94
(100 %)
0 diff
(100 %id)
BF899120 marrow .a 232 to 359 17 to 144       128/144
(88 %)
7 diff
(95.2 %id)
BG403284 bladder, transitional cell papilloma, cell line .a 266 to 859 5 to 595       591/598
(98 %)
2 diff
(99.7 %id)
CN294236 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 324 to 735 1 to 412       412/418
(98 %)
4 diff
(99.1 %id)
DR760167 embryonic stem .a 384 to 1257 6 to 878       873/878
(99 %)
6 diff
(99.4 %id)
BM453009 leiomyosarcoma, uterus .a 430 to 812 443 to 833       391/970
(40 %)
23 diff
(97.7 %id)
BQ307283 breast .a 527 to 1079 1 to 549       549/559
(98 %)
10 diff
(98.3 %id)
AA700427 liver and spleen .a 532 to 946 414 to 1       414/414
(100 %)
5 diff
(98.8 %id)
CB160181 Liver .a 551 to 1168 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
BQ307306 breast .a 572 to 1090 518 to 3       516/519
(99 %)
5 diff
(99.1 %id)
BF984727 duodenal adenocarcinoma, cell line, small intestine .a 591 to 1379 1 to 787       788/934
(84 %)
27 diff
(97.2 %id)
BG257162 embryonal carcinoma, cell line, testis .a 669 to 1315 1 to 647       647/970
(66 %)
11 diff
(98.9 %id)
BF687621 brain, glioblastoma .a 742 to 1406 1 to 651       653/800
(81 %)
34 diff
(95.8 %id)
BF978548 melanotic melanoma, high MDR, skin .a 746 to 1491 1 to 750       750/750
(100 %)
10 diff
(98.7 %id)
CB150849 cervix, Uterine .a 759 to 1352 1 to 594       594/594
(100 %)
6 diff
(99.0 %id)
BF218992 brain, glioblastoma .a 870 to 1552 1 to 668       668/850
(78 %)
24 diff
(97.2 %id)
BF540908 hypernephroma, Kidney .a 898 to 1439 1 to 540       540/643
(83 %)
9 diff
(98.7 %id)
BX431751 fetal liver, Liver .a 901 to 1782 1 to 876       876/876
(100 %)
11 diff
(98.8 %id)
BG679506 skin, squamous cell carcinoma .a 958 to 1784 1 to 831       831/838
(99 %)
15 diff
(98.3 %id)
BX284007 skin, squamous cell carcinoma .a 959 to 1444 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BF038467 adenocarcinoma, ovary .a 970 to 1759 1 to 805       805/1072
(75 %)
47 diff
(95.7 %id)
AL527307 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 975 to 2051 1066 to 1       1066/1072
(99 %)
28 diff
(97.4 %id)
BE889796 leiomyosarcoma, uterus .a 996 to 1735 1 to 741       741/808
(91 %)
12 diff
(98.6 %id)
DN912296   .a 1012 to 1642 631 to 1       631/631
(100 %)
3 diff
(99.6 %id)
BI260526 cervical carcinoma cell line, cervix .a 1016 to 1817 1 to 804       804/805
(99 %)
15 diff
(98.2 %id)
BF246242 brain, glioblastoma .a 1028 to 1557 1 to 538       538/831
(64 %)
31 diff
(96.3 %id)
BI087094 cervix .a 1087 to 1878 1 to 797       797/797
(100 %)
10 diff
(98.8 %id)
AL531914 brain, fetal liver, Liver, neuroblastoma cells .a 1110 to 2044 935 to 1       935/935
(100 %)
3 diff
(99.7 %id)
TI_1948139569   .a 1110 to 2024 1044 to 125       920/1249
(73 %)
22 diff
(98.3 %id)
TI_1948139813   .a 1113 to 2024 1036 to 124       913/1189
(76 %)
26 diff
(97.9 %id)
CN294237 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1137 to 1861 1 to 725       725/725
(100 %)
0 diff
(100 %id)
TI_1948140074   .a 1166 to 2022 1002 to 127       876/1287
(68 %)
37 diff
(97.2 %id)
BF994346 placenta_normal .a 1169 to 1659 22 to 511       490/536
(91 %)
24 diff
(95.6 %id)
AL583241 B cells from Burkitt lymphoma .a 1183 to 2049 887 to 1       887/935
(94 %)
50 diff
(94.7 %id)
AA188980   .a 1211 to 1458 1 to 251       251/258
(97 %)
7 diff
(97.3 %id)
AA189047   .a 1211 to 1498 1 to 292       292/293
(99 %)
13 diff
(95.6 %id)
TI_1948140322   .a 1230 to 2024 919 to 124       796/1230
(64 %)
16 diff
(98.7 %id)
TI_154131255   .a 1236 to 2085 931 to 90   AAA   845/977
(86 %)
25 diff
(97.5 %id)
BI861865 breast, mammary adenocarcinoma, cell line .a 1351 to 1648 22 to 319   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 298/329
(90 %)
6 diff
(98.2 %id)
TI_57193356   .a 1351 to 1658 76 to 383   AAA   308/737
(41 %)
11 diff
(98.6 %id)
TI_154106584   .a 1399 to 2085 773 to 88   AAA   686/687
(99 %)
6 diff
(99.2 %id)
BX333981 Neuroblastoma Cot 50-normalized .a 1405 to 2062 657 to 1       657/657
(100 %)
25 diff
(96.2 %id)
BQ776118 Bone, Human Chondrosarcoma Cell Line .a 1407 to 2085 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
BM995677 Chondrosarcoma, Left Pubic Bone .a 1421 to 2084 682 to 19   AAA   664/664
(100 %)
1 diff
(99.9 %id)
BE857720 Prostate .a 1435 to 2081 652 to 6       647/652
(99 %)
1 diff
(99.9 %id)
BU633554 cell lines, Chondrosarcoma .a 1444 to 2085 659 to 19   AAA   641/641
(100 %)
0 diff
(100 %id)
CA446863 Chondrosarcoma, Left Pubic Bone .a 1447 to 2085 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
BX351284 Neuroblastoma Cot 50-normalized .a 1468 to 2033 567 to 1       567/630
(90 %)
15 diff
(97.7 %id)
BF589484 Prostate .a 1498 to 1837 343 to 4       340/343
(99 %)
22 diff
(93.6 %id)
CN294232 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1499 to 2085 1 to 587   AAA   587/587
(100 %)
1 diff
(99.9 %id)
BJ991539 hepatoblastoma .a 1544 to 2083 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AU151690   .a 1552 to 2078 526 to 1       526/575
(91 %)
5 diff
(99.2 %id)
AW573107 pooled .a 1557 to 1936 380 to 1       380/406
(93 %)
12 diff
(97.1 %id)
AI660156 thymus, pooled .a 1558 to 2086 535 to 9       527/535
(98 %)
5 diff
(99.1 %id)
AA878068 pharynx, squamous cell carcinoma .a 1564 to 2081 518 to 2       517/518
(99 %)
8 diff
(98.5 %id)
AI913466 adenocarcinoma, Pancreas .a 1579 to 2084 511 to 6       506/511
(99 %)
0 diff
(100 %id)
BM806248 leiomyosarcoma, uterus .a 1605 to 2085 1 to 480   AAA   480/480
(100 %)
2 diff
(99.6 %id)
AV718407 corresponding non cancerous liver tissue .a 1607 to 2065 459 to 1     Submitted on the opposite strand 459/459
(100 %)
1 diff
(99.8 %id)
AW069561 bone marrow stroma .a 1613 to 2085 491 to 19   AAA   473/473
(100 %)
1 diff
(99.8 %id)
AA857356 pharynx, squamous cell carcinoma .a 1648 to 2081 434 to 1       434/434
(100 %)
0 diff
(100 %id)
BX372554 Neuroblastoma Cot 25-normalized .a 1652 to 2050 404 to 5       400/494
(80 %)
26 diff
(94.8 %id)
BF084870 lung_normal .a 1658 to 1988 334 to 4       331/334
(99 %)
5 diff
(98.6 %id)
AW362778 colon .a 1659 to 1981 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
BF082771 breast .a 1659 to 1992 336 to 3       334/336
(99 %)
1 diff
(99.8 %id)
AA639709 breast .a 1666 to 2085 420 to 1       420/420
(100 %)
0 diff
(100 %id)
R94766 liver and spleen .a 1690 to 2080 399 to 1       397/416
(95 %)
13 diff
(96.9 %id)
BF447144 Prostate .a 1693 to 2085 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AI866885 adenocarcinoma, Pancreas .a 1705 to 2084 380 to 1       380/380
(100 %)
0 diff
(100 %id)
AA211359   .a 1716 to 2084 369 to 1       369/374
(98 %)
1 diff
(99.8 %id)
AW449014   .a 1737 to 2078 359 to 18   AAA   342/352
(97 %)
1 diff
(99.8 %id)
BU943322 mixed (pool of 40 RNAs) .a 1748 to 2079 1 to 332       332/332
(100 %)
3 diff
(99.1 %id)
AI979323 pooled germ cell tumors .a 1770 to 2078 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
BE672102 pooled germ cell tumors .a 1770 to 2078 309 to 1       309/309
(100 %)
2 diff
(99.4 %id)
AI380253 B-cell, chronic lymphotic leukemia .a 1799 to 2084 286 to 1       286/286
(100 %)
4 diff
(98.7 %id)
AA492580 thyroid .a 1828 to 2086 265 to 7       259/265
(97 %)
0 diff
(100 %id)
AA188981   .a 1833 to 2086 256 to 3       254/258
(98 %)
1 diff
(99.7 %id)
CA311030 Human Lung Epithelial cells, lung .a 1886 to 2085 218 to 19   AAA   200/333
(60 %)
1 diff
(99.7 %id)
DB104211 thymus .b 88 to 529 122 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
CN294242 embryonic stem cells, cell lines H1, H7, andH9 .b 501 to 1222 1 to 725   tiling clone,   725/725
(100 %)
6 diff
(99.2 %id)
CV363738 colon .b 1116 to 1575 1 to 460   tiling clone,   460/472
(97 %)
15 diff
(96.9 %id)
BG624100 placenta .c 1 to 691 1 to 686 W5G I6F L7V P9R E10R ... tiling clone,   686/785
(87 %)
29 diff
(96.4 %id)
BF576929 muscle (skeletal) .d 1 to 696 1 to 691 L143* tiling clone,   691/803
(86 %)
19 diff
(97.7 %id)
BU195785 leiomyosarcoma, uterus .e-u 1 to 832 1 to 834 C13L L14K F15Q V16S K18A ... tiling clone,   834/918
(90 %)
59 diff
(93.6 %id)
W77785 heart .f 1 to 266 1 to 264 M27X L28W tiling clone, fully sequenced,   264/264
(100 %)
2 diff
(99.3 %id)
W72679 heart .f 236 to 632 411 to 7   tiling clone, fully sequenced,   405/411
(98 %)
6 diff
(98.6 %id)
DN918557   .g-u 1 to 583 1 to 580 exact tiling clone,   580/580
(100 %)
6 diff
(99.0 %id)
DN918556   .g-u 38 to 612 575 to 1   tiling clone,   575/575
(100 %)
3 diff
(99.5 %id)
BE543964 cervical carcinoma cell line, cervix .h 1 to 290 1 to 285 Y7I P8L F9L A10H L11Y ... tiling clone,   285/285
(100 %)
6 diff
(97.9 %id)
AV718036 hypothalamus Gene NDC80, variant not shown         Suspected internal deletion, this clone was ignored    
T89463 liver and spleen Gene NDC80, variant not shown         This clone was ignored    
T89551 liver and spleen Gene NDC80, variant not shown         This clone was ignored    
AA911686 pooled Gene NDC80, variant not shown         This clone was ignored    
AI341285 pooled germ cell tumors Gene NDC80, variant not shown         This clone was ignored    
AI341287 pooled germ cell tumors Gene NDC80, variant not shown         This clone was ignored    
AI954614 pooled germ cell tumors Gene NDC80, variant not shown         This clone was ignored    
AI955047 pooled germ cell tumors Gene NDC80, variant not shown         This clone was ignored    
BE503512 pooled germ cell tumors Gene NDC80, variant not shown         This clone was ignored    
BF001266 colon, colon tumor, RER+ Gene NDC80, variant not shown         Suspected internal deletion, this clone was ignored    
BQ776047 Bone, Human Chondrosarcoma Cell Line Gene NDC80, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g-u, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI